← Leaderboards
Samuel Strober
Stanford University
$36,157,957
Attributed
$47,443,478
Total exposure
19
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.9M · FY2005–22$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$73,594,411 · 20
By mechanism
P01$38,738,551 · 10
U01$18,667,844 · 1
R01$16,188,016 · 9
Top collaborators
- Dixon B Kaufman10 shared
- Edgar G. Engleman5 shared
- Robert Lowsky4 shared
- Minnie M Sarwal4 shared
Most similar at Stanford University
Same institution · by research overlap
- Robert S Negrin$29,816,136
- Judith Anne Shizuru$11,975,284
- Edgar G. Engleman$35,389,843
- Asha Bhaskaran Pillai$2,775,962
- Holden T. Maecker$29,621,634
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsT-LymphocyteTransplantationConditioningBaseGraft-Vs-Host DiseaseLymphatic IrradiationAntithymoglobulinMonitorPharmaceutical PreparationsPreventChimerismBone Marrow TransplantationCd8b1 GeneBloodImmuneKidney TransplantationKidneyRegimenCytokineImmune ToleranceClinical ResearchHematopoieticImmunosuppressive Agents
Grant awards (117)
Project 3: Tumor Antigen Reactive Donor T Cell Immunotherapy$328,204
P01 · FY2022 · CA · contact PI
Tomotherapy and Hematopoietic Stem Cells for Tolerance to Kidney Transplants$1,860,947
U01 · FY2021 · AI
Project 3: Tumor Antigen Reactive Donor T Cell Immunotherapy$334,901
P01 · FY2021 · CA · contact PI
Tomotherapy and Hematopoietic Stem Cells for Tolerance to Kidney Transplants$1,860,898
U01 · FY2020 · AI
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation$544,686
P01 · FY2020 · HL · contact PI
Project 3: Tumor Antigen Reactive Donor T Cell Immunotherapy$334,887
P01 · FY2020 · CA · contact PI
Administrative and Biostatistical Core$203,474
P01 · FY2020 · HL · contact PI
Tomotherapy and Hematopoietic Stem Cells for Tolerance to Kidney Transplants$1,860,947
U01 · FY2019 · AI
Blood Stem Cell Transplantation as Immunotherapy$1,739,663
P01 · FY2019 · HL · contact PI
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation$544,686
P01 · FY2019 · HL · contact PI
Role of Dendritic Cells in Mixed Chimerism and Tolerance$399,682
R01 · FY2019 · AI
Project 3: Tumor Antigen Reactive Donor T Cell Immunotherapy$334,864
P01 · FY2019 · CA · contact PI
Administrative and Biostatistical Core$203,474
P01 · FY2019 · HL · contact PI
Tomotherapy and Hematopoietic Stem Cells for Tolerance to Kidney Transplants$1,860,947
U01 · FY2018 · AI
Blood Stem Cell Transplantation as Immunotherapy$1,717,952
P01 · FY2018 · HL · contact PI
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation$537,886
P01 · FY2018 · HL · contact PI
Role of Dendritic Cells in Mixed Chimerism and Tolerance$399,400
R01 · FY2018 · AI
Administrative and Biostatistical Core$200,936
P01 · FY2018 · HL · contact PI
Blood Stem Cell Transplantation as Immunotherapy$1,709,867
P01 · FY2017 · HL · contact PI
Tomotherapy and Hematopoietic Stem Cells for Tolerance to Kidney Transplants$1,024,198
U01 · FY2017 · AI
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation$535,356
P01 · FY2017 · HL · contact PI
Role of Dendritic Cells in Mixed Chimerism and Tolerance$399,135
R01 · FY2017 · AI
Administrative and Biostatistical Core$199,989
P01 · FY2017 · HL · contact PI
Memory CDS T Cells for GVL$150,530
P01 · FY2017 · CA · contact PI
Blood Stem Cell Transplantation as Immunotherapy$1,724,891
P01 · FY2016 · HL · contact PI
Tomotherapy and Hematopoietic Stem Cells For Tolerance to Kidney Transplants$928,696
U01 · FY2016 · AI
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation$499,054
P01 · FY2016 · HL · contact PI
Radiotherapy as Immunotherapy of Tumors$437,914
R01 · FY2016 · CA · contact PI
Role of Dendritic Cells in Mixed Chimerism and Tolerance$398,884
R01 · FY2016 · AI
Administrative and Biostatistical Core$224,215
P01 · FY2016 · HL · contact PI
Memory CDS T Cells for GVL$150,528
P01 · FY2016 · CA · contact PI
Tomotherapy and Hematopoietic Stem Cells For Tolerance to Kidney Transplants$2,622,704
U01 · FY2015 · AI
Radiotherapy as Immunotherapy of Tumors$437,914
R01 · FY2015 · CA · contact PI
Blood Stem Cell Transplantation as Immunotherapy$401,200
P01 · FY2015 · HL · contact PI
Role of Dendritic Cells in Mixed Chimerism and Tolerance$199,324
R01 · FY2015 · AI
Memory CDS T Cells for GVL$150,528
P01 · FY2015 · CA · contact PI
Tomotherapy and Hematopoietic Stem Cells For Tolerance to Kidney Transplants$2,064,580
U01 · FY2014 · AI
Blood Stem Cell Transplantation as Immunotherapy$1,845,101
P01 · FY2014 · HL · contact PI
Radiotherapy as Immunotherapy of Tumors$424,777
R01 · FY2014 · CA · contact PI
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation$346,949
P01 · FY2014 · HL · contact PI
Core A: Administrative and Biostatistical Core$195,060
P01 · FY2014 · HL · contact PI
Memory CDS T Cells for GVL$146,013
P01 · FY2014 · CA · contact PI
Tomotherapy and Hematopoietic Stem Cells For Tolerance to Kidney Transplants$2,570,030
U01 · FY2013 · AI
Blood Stem Cell Transplantation as Immunotherapy$1,792,386
P01 · FY2013 · HL · contact PI
Lupus Glomenulonephritis and NK T cells$456,496
R01 · FY2013 · DK · contact PI
Radiotherapy as Immunotherapy of Tumors$411,640
R01 · FY2013 · CA · contact PI
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation$337,036
P01 · FY2013 · HL · contact PI
Core A: Administrative and Biostatistical Core$189,488
P01 · FY2013 · HL · contact PI
Memory CDS T Cells for GVL$150,528
P01 · FY2013 · CA · contact PI
Tomotherapy and Hematopoietic Stem Cells For Tolerance to Kidney Transplants$2,013,897
U01 · FY2012 · AI
Blood Stem Cell Transplantation as Immunotherapy$1,882,757
P01 · FY2012 · HL · contact PI
Lupus Glomenulonephritis and NK T cells$468,499
R01 · FY2012 · DK · contact PI
Radiotherapy as Immunotherapy of Tumors$437,914
R01 · FY2012 · CA · contact PI
Gene and Cytokine Expression in Tolerance and GVHD$392,040
R01 · FY2012 · AI · contact PI
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation$354,028
P01 · FY2012 · HL · contact PI
Core A: Administrative and Biostatistical Core$199,042
P01 · FY2012 · HL · contact PI
Blood Stem Cell Transplantation as Immunotherapy$1,882,757
P01 · FY2011 · HL · contact PI
Lupus Glomenulonephritis and NK T cells$466,122
R01 · FY2011 · DK · contact PI
Gene and Cytokine Expression in Tolerance and GVHD$392,040
R01 · FY2011 · AI · contact PI
Donor Cell Facilitation of Tolerance$384,700
R01 · FY2011 · AI · contact PI
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation$354,028
P01 · FY2011 · HL · contact PI
Non-Myeloablative Host Conditioning that Protects Against GVHD$314,384
P01 · FY2011 · CA · contact PI
Core A: Administrative and Biostatistical Core$199,042
P01 · FY2011 · HL · contact PI
Blood Stem Cell Transplantation as Immunotherapy$1,882,757
P01 · FY2010 · HL · contact PI
Lupus Glomenulonephritis and NK T cells$482,348
R01 · FY2010 · DK · contact PI
Donor Cell Facilitation of Tolerance$403,570
R01 · FY2010 · AI · contact PI
Gene and Cytokine Expression in Tolerance and GVHD$396,000
R01 · FY2010 · AI
TLI and ATG Conditioning for Combined Kidney and Blood Stem Cell Transplantation$354,028
P01 · FY2010 · HL · contact PI
Non-Myeloablative Host Conditioning that Protects Against GVHD$325,205
P01 · FY2010 · CA · contact PI
Core A: Administrative and Biostatistical Core$199,042
P01 · FY2010 · HL · contact PI
Lupus Glomenulonephritis and NK T cells$474,044
R01 · FY2009 · DK · contact PI
Donor Cell Facilitation of Tolerance$462,039
R01 · FY2009 · AI · contact PI
Gene and Cytokine Expression in Tolerance and GVHD$400,000
R01 · FY2009 · AI · contact PI
Non-Myeloablative Host Conditioning that Protects Against GVHD$320,160
P01 · FY2009 · CA · contact PI
Donor Cell Facilitation of Tolerance$47,965
R01 · FY2009 · AI · contact PI
Blood Stem Cell Transplantation as Immunotherapy$1,844,916
P01 · FY2008 · HL · contact PI
Donor Cell Facilitation of Tolerance$392,051
R01 · FY2008 · AI · contact PI
TLI AND ATG CONDTIONING FOR COMBINED KIDNEY AND BLOOD STEM CELL TRANSPLANTATION$355,626
P01 · FY2008 · HL · contact PI
Non-Myeloablative Host Conditioning that Protects Against GVHD$311,594
P01 · FY2008 · CA · contact PI
Blood Stem Cell Transplantation as Immunotherapy$1,833,243
P01 · FY2007 · HL · contact PI
TLI AND ATG CONDTIONING FOR COMBINED KIDNEY AND BLOOD STEM CELL TRANSPLANTATION$364,514
P01 · FY2007 · HL · contact PI
Mobilized Blood Stem Cell Transplantation without GVHD$342,944
R01 · FY2007 · HL · contact PI
Donor Cell Facilitation of Tolerance$318,237
R01 · FY2007 · AI · contact PI
Non-Myeloablative Host Conditioning that Protects Against GVHD$277,128
P01 · FY2007 · CA · contact PI
Donor Cell Facilitation of Tolerance$79,559
R01 · FY2007 · AI · contact PI
Blood Stem Cell Transplantation as Immunotherapy$1,991,366
P01 · FY2006 · HL · contact PI
TLI/ATG CONDTIONING: KIDNEY/BLOOD STEM CELL TRANSPLANTS$467,693
P01 · FY2006 · HL · contact PI
Mobilized Blood Stem Cell Transplantation without GVHD$353,124
R01 · FY2006 · HL · contact PI
CD4(-) and CD8(-) T Cells in Autoimmune & Normal Mice$314,118
R01 · FY2006 · AI · contact PI
Blood Stem Cell Transplantation as Immunotherapy$1,985,980
P01 · FY2005 · HL
TLI/ATG CONDTIONING: KIDNEY/BLOOD STEM CELL TRANSPLANTS$456,496
P01 · FY2005 · HL
Mobilized Blood Stem Cell Transplantation without GVHD$361,560
R01 · FY2005 · HL
CD4(-) and CD8(-) T Cells in Autoimmune &Normal Mice$321,614
R01 · FY2005 · AI
Blood Stem Cell Transplantation as Immunotherapy$1,916,097
P01 · FY2004 · HL
TLI/ATG CONDTIONING: KIDNEY/BLOOD STEM CELL TRANSPLANTS$435,450
P01 · FY2004 · HL
Mobilized Blood Stem Cell Transplantation without GVHD$361,500
R01 · FY2004 · HL
CD4(-) and CD8(-) T Cells in Autoimmune &Normal Mice$321,552
R01 · FY2004 · AI
Lymphoma Therapy Using Mixed Progenitor Transplants$250,936
R01 · FY2004 · CA
DONOR CELL FACILITATION OF TOLERANCE$237,922
R01 · FY2004 · AI
CORE A- ADMINISTRATION AND BIOSTATISTICS$235,438
P01 · FY2004 · HL
CD4(-) and CD8(-) T Cells in Autoimmune &Normal Mice$319,878
R01 · FY2003 · AI
Lymphoma Therapy Using Mixed Progenitor Transplants$250,796
R01 · FY2003 · CA
DONOR CELL FACILITATION OF TOLERANCE$237,828
R01 · FY2003 · AI
Lymphoma Therapy Using Mixed Progenitor Transplants$250,661
R01 · FY2002 · CA
DONOR CELL FACILITATION OF TOLERANCE$213,965
R01 · FY2002 · AI
NONMYELOABLATIVE HOST CONDITIONING PROTECTS AGAINST GVHD$0
P01 · FY2002 · CA
MOBILIZED BLOOD STEM CELL TRANSPLANTATION WITHOUT GVHD$307,394
R01 · FY2001 · HL
CD4/CD8/ALPHA BETA T CELLS IN AUTOIMMUNE MICE$266,045
R01 · FY2001 · AI
Lymphoma Therapy Using Mixed Progenitor Transplants$250,530
R01 · FY2001 · CA
DONOR CELL FACILITATION OF TOLERANCE$237,653
R01 · FY2001 · AI
T CELLS IN ALLOGENIC HEMATOPOIETIC GRAFTS$0
P01 · FY2001 · CA
MOBILIZED BLOOD STEM CELL TRANSPLANTATION WITHOUT GVHD$299,549
R01 · FY2000 · HL
ALTERNATIVE DEVELOPMENT OF CD4 AND CD8 T CELLS IN MARROW$269,801
R01 · FY2000 · AI
CD4/CD8/ALPHA BETA T CELLS IN AUTOIMMUNE MICE$258,377
R01 · FY2000 · AI
T CELLS IN ALLOGENIC HEMATOPOIETIC GRAFTS$221,448
P01 · FY2000 · CA
DONOR CELL FACILITATION OF TOLERANCE$197,975
R01 · FY2000 · AI
T CELLS IN ALLOGENIC HEMATOPOIETIC GRAFTS$0
P01 · FY2000 · CA